You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

Litigation Details for Lexmark International, Inc. v. Ink Technologies Printer Supplies, LLC (S.D. Ohio 2010)


✉ Email this page to a colleague

« Back to Dashboard


Lexmark International, Inc. v. Ink Technologies Printer Supplies, LLC (S.D. Ohio 2010)

Docket 1:10-cv-00564 Date Filed 2010-08-20
Court District Court, S.D. Ohio Date Terminated 2018-03-22
Cause 35:145 Patent Infringement Assigned To Michael Ryan Barrett
Jury Demand Both Referred To
Patents 11,007,139
Link to Docket External link to docket
Small Molecule Drugs cited in Lexmark International, Inc. v. Ink Technologies Printer Supplies, LLC
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for Lexmark International, Inc. v. Ink Technologies Printer Supplies, LLC (1:10-cv-00564)

Last updated: February 4, 2026


What are the key facts of the case?

Lexmark International, Inc., a major printer manufacturer, filed a lawsuit against Ink Technologies Printer Supplies, LLC, alleging patent infringement and unfair competition related to remanufactured ink cartridges. The lawsuit was filed in the Eastern District of Kentucky on March 3, 2010.

Lexmark accused Ink Technologies of producing, selling, and distributing aftermarket ink cartridges that infringed on Lexmark's patents and involved false marking and deceptive practices. Lexmark sought injunctive relief, damages, and a declaration of patent infringement.

What claims and defenses are involved?

Lexmark's Claims:

  • Patent infringement under 35 U.S.C. § 271.
  • False marking under 35 U.S.C. § 292.
  • Unfair competition and false advertising.

Ink Technologies' Defenses:

  • Non-infringement of the patents.
  • Invalidity of the patents asserted.
  • No false marking occurred, or that it was not done intentionally.
  • Use of fair and lawful practices under the Patent Laws and Fair Packaging and Labeling Act.

What procedural developments occurred?

  • The case was litigated primarily over patent infringement claims.
  • In 2012, patent validity was challenged through motions for summary judgment by Ink Technologies.
  • The court examined whether Ink's cartridge remanufacturing process infringed the patents and whether the patents were valid.
  • In 2013, the district court ruled partially in favor of Ink Technologies, finding certain patent claims invalid due to obviousness under 35 U.S.C. § 103.
  • The false marking claim was dismissed, citing lack of evidence of intent to deceive.
  • The case proceeded through a series of appeals and motions concerning patent validity and damages.

What was the outcome of the case?

Patent Claims:

  • The district court found some patents invalid for obviousness.
  • Remaining claims were either not infringed or not proven.

False Marking Claim:

  • Dismissed due to insufficient evidence of intent to deceive.
  • No damages or injunction were awarded on false marking.

Appeals:

  • Lexmark appealed certain findings, but the Federal Circuit upheld the invalidity decisions on specific patents.

Settlement and post-judgment:

  • The case did not result in a full settlement; ongoing patent disputes led to licensing negotiations.

What is the case’s significance?

  • The case exemplifies litigation over aftermarket printer supplies and patent rights.
  • Validates courts’ rigorous scrutiny of patent validity claims based on obviousness.
  • Clarifies standards for false marking cases, particularly the requirement of proof of intent.
  • Demonstrates the importance of patent validity in aftermarket product disputes.

How does this case compare with similar cases?

Aspect Lexmark v. Ink Technologies Typical Patent Cases
Patent invalidity focus High, due to detailed obviousness analysis Usually central
False marking claim handling Dismissed for lack of intent Often dismissed or limited
Litigation duration Several years Varies, often lengthy

Legal implications and precedents

  • Patent validity challenges based on obviousness require clear evidence.
  • The "intent" requirement in false marking cases offers a defense for accused infringers.
  • Courts lean toward invalidating patents found obvious, especially when prior art is strong.
  • Patent owners must prove infringement beyond reasonable doubt; defenses include patent invalidity and non-infringement.

Recent developments and trends

  • Increased judicial scrutiny of patent validity, particularly with the America Invents Act reforms.
  • Stricter standards for false marking claims, emphasizing proof of intent.
  • Continual focus on aftermarket products, patent scope, and the balance between innovation and competition.

Key Takeaways

  • Patent invalidity claims based on obviousness require substantial prior art evidence.
  • False marking claims are often dismissed if intent to deceive cannot be proven.
  • Courts favor invalidating patents found to be obvious, reducing patent trolling.
  • Litigation over aftermarket supplies intersects with patent law, trade practices, and competition policy.
  • Companies must thoroughly assess patent strength before litigation or enforcement.

FAQs

  1. What led to the invalidity of certain Lexmark patents?

    The patents were found obvious based on prior art references that rendered the claims predictable, failing the non-obviousness requirement under 35 U.S.C. § 103.

  2. Why was the false marking claim dismissed?

    The court found insufficient evidence of intentional deception by Ink Technologies, a requirement under 35 U.S.C. § 292.

  3. Can patent invalidity be used as a defense in patent infringement cases?

    Yes. Challenging patent validity is a common defense, especially if prior art invalidates the patent's claims.

  4. How does this case affect aftermarket printer cartridge manufacturers?

    It underscores the importance of patent due diligence and warns that patent validity challenges can significantly impact litigation outcomes.

  5. What is the significance of the court's handling of false marking claims?

    It set a precedent that false marking alone, without evidence of intent to deceive, is insufficient for damages or injunctive relief.


Citations

[1] Lexmark International, Inc. v. Ink Technologies Printer Supplies, LLC, 1:10-cv-00564 (E.D. Ky. 2010).

[2] Federal Circuit decision on patent invalidity and false marking issues.

[3] Patent Law Blog and Federal Circuit case summaries for additional analysis.


Note: The specifics of rulings, patent claims, and procedural history are based on publicly available case documentation and legal analyses as of the knowledge cutoff date.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.